Declaration of Conflicts of Interest R.L.S. is a principal investigator in the Novavax COVID-19 vaccine trial. C.S. is a sub-investigator in the Novavax COVID-19 vaccine trial. E.C.T. has no conflicts of interest to declare. Views expressed are the authors’ own.Peer reviewedPostprin
The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wel...
In December 2020, COVID-19 vaccination started in many countries, with which the world community hop...
We would like to thank Chen et al. for their comments on our recently published paper in Ageing Rese...
During the COVID-19 pandemic older subjects have been disproportionately affected by the disease. Va...
To access publisher's full text version of this article click on the hyperlink belowDuring the COVID...
During the COVID-19 pandemic older subjects have been disproportionately affected by the disease. Va...
BackgroundOlder adults are more susceptible to severe health outcomes for coronavirus disease 2019 (...
BackgroundOlder adults are more susceptible to severe health outcomes for coronavirus disease 2019 (...
Age is among the most prominent risk factors for developing severe COVID-19 disease, and therefore o...
BACKGROUND Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome...
The SARS-CoV-2 pandemic urgently calls for the development of effective preventive tools. COVID-19 h...
Background: In the ongoing COVID-19 pandemic, advanced age is a risk factor for a severe clinical co...
Background: Mortality rate of COVID-19 infection isexceptionally high in the older population. Vario...
The COVID-19 pandemic brought development, evaluation and use of vaccines for older adults into the ...
Coronavirus disease (COVID-19) has caused a pandemic threatening millions of people worldwide. Yet s...
The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wel...
In December 2020, COVID-19 vaccination started in many countries, with which the world community hop...
We would like to thank Chen et al. for their comments on our recently published paper in Ageing Rese...
During the COVID-19 pandemic older subjects have been disproportionately affected by the disease. Va...
To access publisher's full text version of this article click on the hyperlink belowDuring the COVID...
During the COVID-19 pandemic older subjects have been disproportionately affected by the disease. Va...
BackgroundOlder adults are more susceptible to severe health outcomes for coronavirus disease 2019 (...
BackgroundOlder adults are more susceptible to severe health outcomes for coronavirus disease 2019 (...
Age is among the most prominent risk factors for developing severe COVID-19 disease, and therefore o...
BACKGROUND Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome...
The SARS-CoV-2 pandemic urgently calls for the development of effective preventive tools. COVID-19 h...
Background: In the ongoing COVID-19 pandemic, advanced age is a risk factor for a severe clinical co...
Background: Mortality rate of COVID-19 infection isexceptionally high in the older population. Vario...
The COVID-19 pandemic brought development, evaluation and use of vaccines for older adults into the ...
Coronavirus disease (COVID-19) has caused a pandemic threatening millions of people worldwide. Yet s...
The emergence of SARS-CoV-2 and its inordinately rapid spread is posing severe challenges to the wel...
In December 2020, COVID-19 vaccination started in many countries, with which the world community hop...
We would like to thank Chen et al. for their comments on our recently published paper in Ageing Rese...